Clinical trial
A Pilot Dose-finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-induced Thrombocytopenia
NCT00412464 is registered in ClinicalTrials.gov with Children's Hospital Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Dose-finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-induced Thrombocytopenia
- Lead sponsor
- Children's Hospital Los Angeles
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- December 31, 2009
- Enrollment
- 24 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
heparin-induced thrombocytopenia, thrombosis